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Abstract
Combining fine needle aspirate cytology with flow cytometry immunophenotyping for the rapid
diagnosis of lymphoproliferative lesions is commonplace practice in many institutions. Yet, a
definitive diagnosis of Hodgkin lymphoma in many cases remains elusive, requiring subsequent
tissue biopsy confirmation. In this issue of CytoJournal, Hernandez et al explore the potential role
of using the increased CD4/CD8 T-cell ratio in lymph node fine needle aspiration specimens as a
specific feature in diagnosing Hodgkin lymphoma. CD4/CD8 T-cell ratio comparisons are made
with cytomorphologic diagnoses of reactive, atypical, non-Hodgkin lymphoma, and Hodgkin
lymphoma cases.
Fine needle aspiration (FNA) cytomorphology in con-
junction with flow cytometric (FC) immunophenotyping
has become a reliable and accurate method for the diag-
nosis and classification of many lymphoproliferative dis-
orders. The combined modality approach often allows for
confirmation of diagnosis and subtyping of lymphoma,
and in many cases obviates the necessity for a more inva-
sive open biopsy for many patients with lymphadenopa-
thy [1]. This is especially true in suspected cases of non-
Hodgkin lymphomas (NHL). However, even with the col-
laborative expertise that we and others routinely employ
to reach a consensus diagnosis between the cytopatholo-
gist interpreting the FNA material and the hematopathol-
ogist signing-out the FC data, the diagnosis of Hodgkin
lymphoma (HL) through this method remains difficult. A
FNA diagnosis of HL based purely on cytomorphology is
often followed by tissue biopsy [2].
One of the major difficulties encountered with combined
FNA/FC diagnosis of HL is identifying sufficient numbers
of the neoplastic cells for subsequent phenotypic analysis.
In most instances, too few malignant cells for FC can be
obtained from the tumors, either by FNA or biopsy mate-
rial. This is due, in large part, to the cellular makeup of HL,
in which the inflammatory background cells outnumber
the malignant RS cells and variants by 10–100 fold. In
addition, the neoplastic cells exhibit high cellular fragility,
and are associated with a fibrous stroma interfering with
cellular dispersion. This has led to Herculean gating
efforts to isolate the RS cells and phenotype them with
CD30 and CD15 [3,4]. Many other studies have looked at
the components of the normal background T-lymphocyte
populations present in HL, where it has long been known
that there is a relative preponderance of CD4-positive T-
cells, with an increased helper/cytotoxic CD4/CD8 ratio
by immunohistochemistry [5-7]. We know that the RS
cells and variants within the lymph node affect the sur-
rounding cells, which results in alterations of the propor-
tion between T and B lymphocytes and the activation of
these cells, and that the relative proportion of the back-
ground lymphocytes differs depending upon the histo-
logic subtype of the HL [8]. While the nature and
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composition of the background reactive lymphocytes is
helping to increase our basic understanding of the patho-
genesis of the disease, it can hardly be used as a specific
diagnostic feature.
In the current issue of Cytojournal, Hernandez et al com-
pare 85 cases of combined FNA/FC lymph nodes with an
increased CD4/CD8 ratio (>4), and demonstrate no
definitive quantitative differences in T-lymphocyte distri-
bution between HL, NHL, and benign reactive lymph
nodes. They report that the average CD4/CD8 ratio was
essentially identical in reactive, HL, and NHL cases. This
should not be surprising given the extraordinary variation
in lymphocyte components in many lymphoproliferative
processes. T-cell rich large B-cell lymphoma and nodular
lymphocyte predominant HL are just two tumors which
quickly come to mind. Both of these tumors can morpho-
logically mimic classical HL particularly on FNA material,
with only a minor population of malignant RS-like cells
within a sea of reactive small lymphocytes. Phenotypic
studies confirm that CD4-positive cells may exceed the
CD8-positive background lymphocytes [10,11].
In a recent report by Ravoet, et al, FC was combined with
lymph node biopsy to help discriminate HL, NHL, carci-
noma, and reactive diagnoses [4]. Median CD4/CD8
ratios in HL were 5.0 (range 1.6–10.4), which was similar
to that seen in granulomatous lymph nodes (median 3.2,
range 1.5–11.8), and reactive hyperplasia (median 2.71,
range 0.4–18.6). They concluded that given the large scat-
tering of the CD4/CD8 ratios within each group, the use
of the CD4/CD8 ratio is not recommended in clinical
practice in order to diagnosis HL.
A quick review over the past year of lymph node FNAs per-
formed at our institution reveals a similar wide scattering
of ratios. We identified 6 cases of FNA suspected HL with
a median CD4/CD8 ratio of 9.7 (range 0.3–42.5). Subse-
quent nodal biopsies confirmed HL in all cases. The CD4/
CD8 ratio was less than 4 in half of these cases. Interest-
ingly, one patient with an HIV-associated HL predictably
had a reverse ratio, another potential pitfall. Equally
important though were the six additional cases of sus-
pected HL by FNA in which the specimens received for FC
were inadequate, containing too few cells to phenotype.
Thus, we rely exclusively on the morphologic features
present within the FNA smears, combined with confirma-
tory immunohistochemical studies performed on cell
block material to diagnosis HL with confidence. Other-
wise, a nodal biopsy is and should be recommended [1].
Integration of clinical and biological features is one of the
basic tenets of the WHO classification of lymphoprolifer-
ative disorders. While combined FNA/FC is extremely use-
ful in the diagnosis and subclassification of some
lymphoproliferative disorders, it is not without limitation
and is not the end of the diagnostic line. Until we know
more about the characteristics of the T-cell milieu of HL
and can point to a more specific phenotype which can be
detected by FC, we must continue to rely on other ancil-
lary tools for a definitive HL diagnosis. The work of Hern-
andez et al is important to remind us that an increased
CD4/CD8 ratio is only one phenotypic clue present in HL,
and a non-specific clue at that.
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